Melanoma and other Skin Tumours
Access all ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Knowledge Portal
Preselected recommended educational resources on Melanoma.
Karl Lewis reports the results of a study of adjuvant vemurafenib in patients with completely resected BRAF V600+ melanoma at high risk for recurrence, addressing the very legitimate question of the activity in adjuvant setting after seeing its impact in the metastatic setting.